TGFB1 and systemic sclerosis: Clinical and pathological SSc is characterized by fibrosis accompanied by massive α-SMA-positive myofibroblasts, accumulation of ECM proteins (collagens, elastin, glycosaminoglycans, tenascin, and fibronectin) in tissue, and regulation of growth factor (TGF)-β and other profibrotic mediators (57).